Save Klisyri as a Last Resort for Actinic Keratosis

July 2021

Klisyri (tirbanibulin) 1% ointment will be a new topical Rx for actinic keratosis.

It’ll be touted as the only 5-day treatment for actinic keratosis...compared to other topicals (Aldara, Efudex, etc) that need to be used for at least 2 to 16 weeks.

But there’s no proof Klisyri works better or has fewer side effects. Plus it costs nearly $1,000 for a 5-day course.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

COVID-19 Tackle the Latest COVID-19 Vaccine Questions
COVID-19 Don’t Rely on Antibody Testing to Assess COVID-19 Immunity
Contraceptives Expect Questions About Nextstellis for Contraception
Kidney Stones Be Ready to Help Treat and Prevent Kidney Stones
Infectious Diseases Know When “Shorter Is Better” With Antibiotics
Bites & Stings Review First Aid Strategies for Jellyfish and Scorpion Stings
Sleep Disorders Reinforce Nondrug Measures for Jet Lag
Diabetes Emphasize Proper Foot Care for Patients With Diabetes
Dermatology Save Klisyri as a Last Resort for Actinic Keratosis
Med Safety Watch for Unexpected Ingredients in New Zantac Products
Hypertension Know the Ins and Outs of Selecting IV Antihypertensives
Bites & Stings Explain the Differences Between Snakebite Antivenoms
Substance Use Disorder Start Buprenorphine for Opioid Use Disorder in the Hospital

Save Klisyri as a Last Resort for Actinic Keratosis

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents